{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:25:45Z","timestamp":1791473145974,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012270","name":"Shaanxi Key Science and Technology Innovation Team Project","doi-asserted-by":"publisher","award":["2021TD-43"],"award-info":[{"award-number":["2021TD-43"]}],"id":[{"id":"10.13039\/501100012270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002740"],"award-info":[{"award-number":["82002740"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"publisher","award":["2023-YBSF-481"],"award-info":[{"award-number":["2023-YBSF-481"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shaanxi Provincial Youth Science and Technology Nova Cultivation Project","award":["2021KJXX-25"],"award-info":[{"award-number":["2021KJXX-25"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-025-04270-0","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T11:43:42Z","timestamp":1756295022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Extracellular vesicle-derived lncRNA-GC1 serves as a novel biomarker for predicting and monitoring the immunotherapeutic outcomes of patients with gastric cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Jiangpeng","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danhong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"issue":"1","key":"4270_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamasurg.2021.5104","volume":"157","author":"C Huang","year":"2022","unstructured":"Huang C, Liu H, Hu Y, et al. Laparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer: Five-Year Outcomes From the CLASS-01 Randomized Clinical Trial. JAMA Surg. 2022;157(1):9\u201317.","journal-title":"JAMA Surg"},{"issue":"12","key":"4270_CR2","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1136\/gutjnl-2021-325948","volume":"71","author":"Z Wang","year":"2022","unstructured":"Wang Z, Han W, Xue F, et al. Nationwide gastric cancer prevention in China, 2021\u20132035: a decision analysis on effect, affordability and cost-effectiveness optimisation. Gut. 2022;71(12):2391\u2013400.","journal-title":"Gut"},{"issue":"3","key":"4270_CR3","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"4270_CR4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ejca.2021.07.039","volume":"157","author":"T Dyba","year":"2021","unstructured":"Dyba T, Randi G, Bray F, et al. The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer. 2021;157:308\u201347.","journal-title":"Eur J Cancer"},{"issue":"8","key":"4270_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11912-019-0820-4","volume":"21","author":"FM Johnston","year":"2019","unstructured":"Johnston FM, Beckman M. Updates on Management of Gastric Cancer. Curr Oncol Rep. 2019;21(8):67.","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"4270_CR6","first-page":"264","volume":"71","author":"SS Joshi","year":"2021","unstructured":"Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71(3):264\u201379.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"4270_CR7","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s40291-019-00424-y","volume":"23","author":"MA Pereira","year":"2019","unstructured":"Pereira MA, Ramos M, Dias AR, et al. Expression Profile of Markers for Targeted Therapy in Gastric Cancer Patients: HER-2, Microsatellite Instability and PD-L1. Mol Diagn Ther. 2019;23(6):761\u201371.","journal-title":"Mol Diagn Ther"},{"issue":"2","key":"4270_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/bfgp\/ely019","volume":"18","author":"Q Zhao","year":"2019","unstructured":"Zhao Q, Cao L, Guan L, et al. Immunotherapy for gastric cancer: dilemmas and prospect. Brief Funct Genomics. 2019;18(2):107\u201312.","journal-title":"Brief Funct Genomics"},{"issue":"2","key":"4270_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188615","volume":"1876","author":"K Li","year":"2021","unstructured":"Li K, Zhang A, Li X, Zhang H, Zhao L. Advances in clinical immunotherapy for gastric cancer. Biochim Biophys Acta Rev Cancer. 2021;1876(2): 188615.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"4270_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5230\/jgc.2024.24.e5","volume":"24","author":"HS Han","year":"2024","unstructured":"Han HS, Lee KW. Liquid Biopsy: An Emerging Diagnostic, Prognostic, and Predictive Tool in Gastric Cancer. J Gastric Cancer. 2024;24(1):4\u201328.","journal-title":"J Gastric Cancer"},{"issue":"1","key":"4270_CR11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/ueg2.12328","volume":"11","author":"C Lopes","year":"2023","unstructured":"Lopes C, Chaves J, Ortig\u00e3o R, Dinis-Ribeiro M, Pereira C. Gastric cancer detection by non-blood-based liquid biopsies: A systematic review looking into the last decade of research. United European Gastroenterol J. 2023;11(1):114\u201330.","journal-title":"United European Gastroenterol J"},{"issue":"6","key":"4270_CR12","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1002\/1878-0261.12901","volume":"15","author":"M Labib","year":"2021","unstructured":"Labib M, Kelley SO. Circulating tumor cell profiling for precision oncology. Mol Oncol. 2021;15(6):1622\u201346.","journal-title":"Mol Oncol"},{"key":"4270_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.672195","volume":"11","author":"F Chemi","year":"2021","unstructured":"Chemi F, Mohan S, Guevara T, Clipson A, Rothwell DG, Dive C. Early Dissemination of Circulating Tumor Cells: Biological and Clinical Insights. Front Oncol. 2021;11: 672195.","journal-title":"Front Oncol"},{"issue":"3","key":"4270_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1158\/0008-5472.CAN-21-1718","volume":"82","author":"JC Stadler","year":"2022","unstructured":"Stadler JC, Belloum Y, Deitert B, et al. Current and Future Clinical Applications of ctDNA in Immuno-Oncology. Cancer Res. 2022;82(3):349\u201358.","journal-title":"Cancer Res"},{"issue":"4","key":"4270_CR15","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ccell.2020.03.012","volume":"37","author":"E Kilgour","year":"2020","unstructured":"Kilgour E, Rothwell DG, Brady G, Dive C. Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance. Cancer Cell. 2020;37(4):485\u201395.","journal-title":"Cancer Cell"},{"issue":"1","key":"4270_CR16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41392-021-00779-x","volume":"6","author":"C Li","year":"2021","unstructured":"Li C, Ni YQ, Xu H, et al. Roles and mechanisms of exosomal non-coding RNAs in human health and diseases. Signal Transduct Target Ther. 2021;6(1):383.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"4270_CR17","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1080\/15476286.2020.1729584","volume":"17","author":"JP Tosar","year":"2020","unstructured":"Tosar JP, Cayota A. Extracellular tRNAs and tRNA-derived fragments. RNA Biol. 2020;17(8):1149\u201367.","journal-title":"RNA Biol"},{"issue":"1","key":"4270_CR18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12943-020-01199-1","volume":"19","author":"W Hu","year":"2020","unstructured":"Hu W, Liu C, Bi ZY, et al. Comprehensive landscape of extracellular vesicle-derived RNAs in cancer initiation, progression, metastasis and cancer immunology. Mol Cancer. 2020;19(1):102.","journal-title":"Mol Cancer"},{"issue":"7","key":"4270_CR19","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1001\/jamasurg.2020.1133","volume":"155","author":"X Guo","year":"2020","unstructured":"Guo X, Lv X, Ru Y, et al. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study. JAMA Surg. 2020;155(7):572\u20139.","journal-title":"JAMA Surg"},{"issue":"7","key":"4270_CR20","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1158\/2159-8290.CD-15-0921","volume":"6","author":"TT Sun","year":"2016","unstructured":"Sun TT, He J, Liang Q, et al. LncRNA GClnc1 Promotes Gastric Carcinogenesis and May Act as a Modular Scaffold of WDR5 and KAT2A Complexes to Specify the Histone Modification Pattern. Cancer Discov. 2016;6(7):784\u2013801.","journal-title":"Cancer Discov"},{"key":"4270_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103971","volume":"78","author":"Q Song","year":"2022","unstructured":"Song Q, Lv X, Ru Y, et al. Circulating exosomal gastric cancer-associated long noncoding RNA1 as a noninvasive biomarker for predicting chemotherapy response and prognosis of advanced gastric cancer: A multi-cohort, multi-phase study. EBioMedicine. 2022;78: 103971.","journal-title":"EBioMedicine"},{"key":"4270_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2021.106165","volume":"96","author":"G Mathew","year":"2021","unstructured":"Mathew G, Agha R, Albrecht J, et al. STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Int J Surg. 2021;96: 106165.","journal-title":"Int J Surg"},{"issue":"6","key":"4270_CR23","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41556-022-00919-7","volume":"24","author":"M Cao","year":"2022","unstructured":"Cao M, Isaac R, Yan W, et al. Cancer-cell-secreted extracellular vesicles suppress insulin secretion through miR-122 to impair systemic glucose homeostasis and contribute to tumour growth. Nat Cell Biol. 2022;24(6):954\u201367.","journal-title":"Nat Cell Biol"},{"issue":"11","key":"4270_CR24","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.annonc.2021.08.1748","volume":"32","author":"Y Loriot","year":"2021","unstructured":"Loriot Y, Marabelle A, Gu\u00e9gan JP, et al. Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance. Ann Oncol. 2021;32(11):1381\u201390.","journal-title":"Ann Oncol"},{"issue":"10","key":"4270_CR25","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/s41419-022-05350-2","volume":"13","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Wu H, Chong W, Shang L, Jing C, Li L. Liquid biopsy in gastric cancer: predictive and prognostic biomarkers. Cell Death Dis. 2022;13(10):903.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4270_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12943-023-01715-z","volume":"22","author":"S Ma","year":"2023","unstructured":"Ma S, Zhou M, Xu Y, et al. Clinical application and detection techniques of liquid biopsy in gastric cancer. Mol Cancer. 2023;22(1):7.","journal-title":"Mol Cancer"},{"issue":"12","key":"4270_CR27","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.3748\/wjg.v30.i12.1680","volume":"30","author":"C D\u00edaz Del Arco","year":"2024","unstructured":"D\u00edaz Del Arco C, Fern\u00e1ndez Ace\u00f1ero MJ, Ortega ML. Liquid biopsy for gastric cancer: Techniques, applications, and future directions. World J Gastroenterol. 2024;30(12):1680\u2013705.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4270_CR28","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12943-022-01684-9","volume":"21","author":"T Guo","year":"2022","unstructured":"Guo T, Tang XH, Gao XY, et al. A liquid biopsy signature of circulating exosome-derived mRNAs, miRNAs and lncRNAs predict therapeutic efficacy to neoadjuvant chemotherapy in patients with advanced gastric cancer. Mol Cancer. 2022;21(1):216.","journal-title":"Mol Cancer"},{"issue":"2","key":"4270_CR29","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1053\/j.gastro.2023.02.044","volume":"165","author":"X Guo","year":"2023","unstructured":"Guo X, Peng Y, Song Q, et al. A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients. Gastroenterology. 2023;165(2):402-413.e13.","journal-title":"Gastroenterology"},{"issue":"5","key":"4270_CR30","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41419-020-2531-z","volume":"11","author":"J Yang","year":"2020","unstructured":"Yang J, Gong Y, Lam VK, et al. Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer. Cell Death Dis. 2020;11(5):346.","journal-title":"Cell Death Dis"},{"issue":"11","key":"4270_CR31","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1080\/14737159.2020.1842199","volume":"20","author":"E Abdi","year":"2020","unstructured":"Abdi E, Latifi-Navid S, Abdi F, Taherian-Esfahani Z. Emerging circulating MiRNAs and LncRNAs in upper gastrointestinal cancers. Expert Rev Mol Diagn. 2020;20(11):1121\u201338.","journal-title":"Expert Rev Mol Diagn"},{"key":"4270_CR32","doi-asserted-by":"crossref","unstructured":"Noepel-Duennebacke S, Juette H, Schulmann K, et al. Microsatellite instability (MSI-H) is associated with a high immunoscore but not with PD-L1 expression or increased survival in patients (pts.) with metastatic colorectal cancer (mCRC) treated with oxaliplatin (ox) and fluoropyrimidine (FP) with and without bevacizumab (bev): a pooled analysis of the AIO KRK 0207 and RO91 trials. J Cancer Res Clin Oncol. 2021. 147(10): 3063\u20133072.","DOI":"10.1007\/s00432-021-03559-w"},{"issue":"1","key":"4270_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/15384047.2022.2038002","volume":"23","author":"T Yoshida","year":"2022","unstructured":"Yoshida T, Ogura G, Tanabe M, et al. Clinicopathological features of PD-L1 protein expression, EBV positivity, and MSI status in patients with advanced gastric and esophagogastric junction adenocarcinoma in Japan. Cancer Biol Ther. 2022;23(1):191\u2013200.","journal-title":"Cancer Biol Ther"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04270-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04270-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04270-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:49:23Z","timestamp":1757443763000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-04270-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4270"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04270-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4981595\/v1","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"27 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and registered with ClinicalTrials.gov, NCT05334849. All participants provided informed written consent. This study was approved by the Institutional Ethics Committees and Review Board of the Air Force 986th Hospital (KYLL-2020\u2013986-28), Xijing Hospital (KY20212226-C-1), and the Chinese People\u2019s Liberation Army General Hospital (S2020-606\u201304), respectively.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"I hereby consent to the publication of this article in the BMC Medicine.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"499"}}